ABSTRACT
Context Individuals with youth-onset type 2 diabetes mellitus (T2DM) display substantial, but unexplained, heterogeneity in their clinical presentations and risk of complications such as diabetic neuropathy. Data-driven clustering may be useful in characterizing this heterogeneity.
Objective To identify data-driven subphenotypes of newly diagnosed youth-onset T2DM and study their association with distal symmetric polyneuropathy (DSPN) at time of diagnosis.
Design Cross-sectional
Setting USA
Participants 641 individuals with newly diagnosed T2DM aged 10-19 years from the SEARCH for Diabetes in Youth Study and the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study.
Exposure(s) Body mass index, HbA1c, fasting C-peptide, systolic blood pressure, diastolic blood pressure, LDL cholesterol and HDL cholesterol
Main Outcome Measures Data-driven subphenotypes were identified from k-means clustering. The cross-sectional association of subphenotypes with DSPN, based on expert examination scores (≥2.5) from the Michigan Neuropathy Screening Instrument, were assessed using Poisson regressions with robust standard errors.
Results Among 641 youth-onset T2DM, 58.2% were female, with 38.2% of participants ≤13 years having average BMI of 34.5 kg/m2 (SD: 6.5 kg/m2), and average HbA1c of 6.1% (IQR: 5.6-7.0). Three youth-onset subphenotypes were identified: mild obesity related diabetes (yMOD, 48.5%), severe insulin deficient diabetes (ySIDD, 18.7%) and severe insulin resistant diabetes (ySIRD, 32.7%). After adjusting for covariates, the prevalence of abnormal DSPN were 2.58 (95%CI: 1.74, 3.81) and 2.02 (95%CI: 1.40, 2.93) times among those classified as the ySIDD and ySIRD subphenotypes, relative to the yMOD subphenotype.
Conclusions Youth-onset T2DM consisted of heterogeneous clinical subphenotypes with differences prevalence of DSPN. Management of youth-onset T2DM may need to consider strategies tailored to each subphenotype.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by National Institutes of Health: P30DK111024 (Ali)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We were exempt from ethical approval by the Institutional Review Board of Emory University.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability statement
The code for the analysis is available on https://github.com/jvargh7/diabetes_subphenotypes_youth. Data for SEARCH and TODAY are available from the NIDDK Biorepository.
Abbreviations
- MNSI
- Michigan Neuropathy Screening Instrument
- T1DM
- Type 1 Diabetes
- T2DM
- Type 2 Diabetes
- DAA
- Diabetes Associated Antibody
- DSPN
- Distal Symmetric Polyneuropathy
- yMOD
- Youth-onset Mild Obesity-related Diabetes
- ySIDD
- Youth-onset Severe Insulin-Deficient Diabetes
- ySIRD
- Youth-onset Severe Insulin-Resistant Diabetes